NorthWest Biotherapeutics Inc (NWBO)

[sukus]

Great analysis H2R. I was wondering too about that external control % there why it shows 15% at 3 years. Seems that number was an inflated number from my first impression. I agree with your friend who put the SOC number at 5% at 3 years.

Thanks to you. You explained that numbers included the loss to follow up patients. That answered my questions. If loss to follow up was not included, it would be very likely to reach 5% at 3 years.

Looks to me NWBO puts very conservative estimates so no one can blame NWBO.

Too conservative I think. NWBO might have a very good reason. I trust them that they have a strong reason to do it that way.